Authors

• Loes Maria Latten-Jansen
• Christopher Jackson (ORCID: https://orcid.org/0000-0001-6150-709X)
• Heather Vezina (ORCID: https://orcid.org/0000-0002-0522-9264)
• Devanand Joseph
• Balmeet Gurm
• Matías Chacón (ORCID: https://orcid.org/0000-0001-6872-4185)
• Iwona Ługowska (ORCID: https://orcid.org/0000-0001-9511-178X)
• R. Donald Harvey (ORCID: https://orcid.org/0000-0002-4217-1313)
• Urvi Aras
• Rastislav Bahleda (ORCID: https://orcid.org/0009-0001-8245-0544)
• Sara Lonardi (ORCID: https://orcid.org/0000-0002-7593-8138)
• Marcelo Garrido (ORCID: https://orcid.org/0000-0001-8905-8986)
• José Trigo (ORCID: https://orcid.org/0000-0002-4489-2683)
• Richard North
• Aitana Calvo (ORCID: https://orcid.org/0000-0002-7470-8517)
• Bryan Bennett (ORCID: https://orcid.org/0000-0002-5295-5576)
• Armando Santoro (ORCID: https://orcid.org/0000-0003-1709-9492)
• Linghui Li (ORCID: https://orcid.org/0000-0002-1371-1317)
• Anne O’Donnell (ORCID: https://orcid.org/0000-0003-4710-7545)
• Deepak Perumal
• Wee-Teck Ng

Institutions

• Humanitas University (IT)
• Emory University (US)
• Pontificia Universidad Católica de Chile (CL)
• Université Paris-Saclay (FR)
• Maastricht University Medical Centre (NL)
• Wellington Hospital (NZ)
• Institut Gustave Roussy (FR)
• Dunedin Public Hospital (NZ)
• Hospital General Universitario Gregorio Marañón (ES)
• Clínica Las Condes (CL)
• Bristol-Myers Squibb (United States) (US)
• Tauranga Hospital (NZ)
• Istituto Oncologico Veneto (IT)
• Bristol-Myers Squibb (United Kingdom) (GB)
• Instituto Alexander Fleming (AR)
• The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)
• Hospital Clínico Universitario Virgen de la Victoria (ES)
• IRCCS Humanitas Research Hospital (IT)
• Instituto de Investigación Biomédica de Málaga (ES)
• Winship Cancer Institute
• Bristol-Myers Squibb (Switzerland) (CH)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2025-10-01

DOI

https://doi.org/10.1136/jitc-2025-011918

Primary Topic

CAR-T cell therapy research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Bristol-Myers Squibb
• Medical Research Council